2016 American Transplant Congress

Sunday, June 12, 2016

3:06pm-3:18pm

Clinical Significance of Non-HLA Antibodies in the Development of Microcirculation Inflammation in Allograft Tissue After Kidney Transplantation.

J. Min,^1,3 H. Lee,^2,3 B. Chung,^1,3 E.-J. Oh,^2,3 C. Yang.^1,3

Concurrent Session: Novel Markers of Long Term Kidney Transplant Outcomes  •  Ballroom A

3:06pm-3:18pm

Does DCD Donor Time-to-Death After Withdrawal of Support Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.

J. Scalea, L. Fernandez, A. D'Alessandro, M. Anderson, D. Foley, J. Mezrich.

Concurrent Session: Kidney Transplantation: Outcomes, Matching and Marginal Donors  •  Ballroom B

3:06pm-3:18pm

Everolimus in Combination with Reduced Dose Tacrolimus Is Effective as a Prophylaxis of Acute Rejection in Low-to-Moderate Immunologic Risk De Novo Kidney Transplantation Patients.

Y. Qazi, F. Shihab, S. Mulgaonkar, K. MaCague, D. Patel.

Concurrent Session: Kidney Transplant: CNI Minimization  •  Room 311

3:06pm-3:18pm

Kidney Retransplantation Is Associated with Higher Mortality Risk Among HIV+ vs. HIV- Recipients.

B. Shelton,¹ S. Mehta,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ S. Gustafson,³ C. Durand,⁴ D. Segev,⁴ J. Locke.¹

Concurrent Session: SOT: HIV, HBV, & HCV  •  Room 313

3:06pm-3:18pm

Monitoring of De Novo DSA Post Alemtuzumab Induction in Renal Transplant Recipients: One Year Follow Up.

Y. Nigatu, C. Estrada, F. Darras, H. Suh, M. Abate, E. Nord.

Concurrent Session: Policy and Practice: Implications for Long Term Outcomes  •  Room 312

3:06pm-3:18pm

Post-Transplant T-Cell Alloreactive Perturbation Precedes the Advent of Humoral Immunity in Kidney Transplant Patients.

E. Crespo,¹ S. Luque,¹ J. Cruzado,² E. Melilli,² J. Grinyo,² M. Lucia,¹ O. Bestard.²

Concurrent Session: Kidney Acute Cellular Rejection: Clinical Outcomes and Pathological Characteristics  •  Ballroom C

3:06pm-3:18pm

Risk of ESRD in Potential HIV+ Live Kidney Donors.

A. Muzaale,¹ L. Kucirka,¹ A. Massie,¹ C. Durand,¹ J. Locke,² G. Lucas,¹ D. Segev.¹

Concurrent Session: Living Kidney Donation: Risk Factors for Adverse Long term Outcome  •  Veterans Auditorium

3:06pm-3:18pm

The “PHS Increased Risk” Label Is Associated with Non-Utilization of Hundreds of Organs Per Year.

M. Volk,¹ A. Wilk,² C. Wolfe,³ D. Kaul.⁴

Concurrent Session: Donor Management: All Organs  •  Room 306

3:06pm-3:18pm

Using Predictive Modeling to Manage Cardiovascular Risk and Improve Kidney Transplant Outcomes.

W. Moran, J. Zhang, Z. Su, D. Taber, P. Mauldin, T. Srinivas.

Concurrent Session: Cardiovascular Complications in Kidney Transplantation  •  Room 304

3:18pm-3:30pm

Are We Refusing Good Organs? Outcomes of Ventilator Management of Sub-Optimal Lung Donors.

B. Scully,¹ D. Horne,¹ J. Heinle,¹ E. McKenzie,¹ K. Hosek,² W. Zhang,² G. Mallory,³ E. Melicoff.³

Concurrent Session: Donor Management: All Organs  •  Room 306